Important legal notice
Contact   |   Search on Europa   

Combatting Deadly Diseases Graphic element print icon Graphic element
  Homepage
Graphic element General information
  RTD Poverty-Related Diseases Unit
  Developing countries
  EDCTP
   
Graphic element Projects
  About FP6 Funding
  FP6 projects
  About FP5 Funding
  FP5 projects
   
   
Graphic element Addressed Diseases
  HIV/AIDS
- News
  Malaria
  Tuberculosis
   
Graphic element Calls for proposals
  4th call
Closed 9 Nov. 2005
   
Graphic element Contact corner
  Unit
  Scientific officers
  Subscribe to our mailing list
   
 

Coordinators list

List of project (sorted by Coordinator)

AABY Peter BCGNSE
BCG Vaccination and Childhood Morbidity and Mortality: Interventions with Possible Implications for Immunisation Policy in Developing Countries
AARØ Leif Edvard SATZ
Promoting Sexual and Reproductive Health. School-Based HIV/AIDS Prevention in Sub-Saharan Africa
ALONSO Pedro L. Malaria Age Exposure
Age of Exposure and Immunity to Malaria in Infants
ARNOT David EUROMALVAC1
A European Malaria Vaccine Development Consortium
EUROMALVAC-2
The Second Phase of a European Malaria Vaccine Development Consortium
AUTRAN Brigitte THERAVAC
Evaluation of a Therapeutic Vaccination Strategy for HIV-1 Infection TheraVac
BALZARINI Jan HIV RESISTANCE
New Tools to Investigate and Suppress HIV Drug Resistance
BARNETT D Teach CD4
International CD4 T-Lymphocyte Training Programme for the Support of HIV Clinical Trials Networks
BEITZ Eric MalariaPorin
Validation of the Plasmodium Aquaglyceroporin as a Drug Target
BENKIRANE Monsef HIDDEN HIV CHALLENGE
Challenging the Hidden HIV: Understanding the Block on Transcriptional Reactivation to Eradicate Infection
BERNEY Helen DISSARM
Development of Integrable Sensors for Screening of Antibiotic Resistance in Mycobacterium
BOELAERT Marleen PARASAC
Organisation of an International Conference: Moving targets - Parasites, Resistance and Access to Drugs from 4-6 December 2000
BÖTTGER Erik C. TB prevention cluster
New Strategies for Treatment and Prevention of Mycobacterial Diseases
BOUCHER Charles AB EuropeHIVResistance
European Cohort Coordinating Network on HIV Drug Resistance
UNITE-MORE
Uniformity in Testing and Monitoring HIV Resistance
BOUCHER Charles
and WENSING Annemarie
SPREAD
Strategy to Control SPREAD of HIV Drug Resistance
BRABIN Bernard PREMA-EU
A Cost-Shared Concerted Action on Malaria and Anaemia Control in Pregnant Women
BUV Anne ORISS Project
Operational Research in STI and Related Services for Women in High-Risk Situations in Cambodia and Thailand
CHIMINI Giovana MPCM
Pathogenic Role of MicroParticles in Cerebral Malaria
COLE Stewart T. NM4TB
New Medicines for Tuberculosis
X-TB
Structural and Functional Genomics of Mycobacterium Tuberculosis
COOSEMANS Marc MALVECASIA
Monitoring Insecticide Resistance and Mapping Malaria Vectors in Southeast Asia : A Prerequisite for Sustainable Malaria Vector Control
CUTTING Simon M. INNOVAC
Highly Innovative Strategies for Vaccination to Poverty Related Diseases
DALESSANDRO Umberto LAMNET
New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa
DARBYSHIRE Janet CASCADE
Concerted Action on SeroConversion to AIDS and Death in Europe
DEGETT Jens EAGLES
European Action in Global Life Sciences - Health Programme
DO ROSRIO Virglio E. RESMALCHIP
Development of a Malaria-Resistant DNA Chip as a Public Health Tool for the Management of Plasmodium Falciparum Malaria Drug Resistance
DOERIG Christian SIGMAL
Targeting Malaria Transmission Through Interference with Signalling in Plasmodium falciparum Gametocytogenesis
DRUILHE Pierre EMLI
Phase-I and II Trials of the Malaria Pre-Erythrocytic Vaccine LSA-3 and Refinement of Measurable Outcomes
DUJARDIN Bruno DOT AFRICAN TRIAL
A Multicentre Randomised Trial of Directly Observed Treatment for Tuberculosis Patients in Sub-Saharan Africa
ENSOLI Barbara AVIP
Aids Vaccine Integrated Project
EUGEN-OLSEN Jesper TB Treatment Marker
Establishing a TB Treatment Efficacy Marker
FAXELID Elisabeth Bridging gaps
Bridging the Gaps Between Public and Traditional Healthcare Sectors Testing a Model to Improve Quality of STI/HIV/AIDS Care in sub-Saharan Africa
FERRANTELLI Flavia VIAV
Very Innovative AIDS Vaccine
FISCHER Rainer PHARMA-PLANTA
Recombinant Pharmaceuticals from Plants for Human Health
GARCIA Maria J. CELL CYCLE & DORMANCY IN TB
Regulation of the Cell Cycle and Dormancy in Mycobacterium Tuberculosis
GIANQUITO Carlo PENTA/ECS
Paediatric European Network for Treatment of AIDS and European Collaborative Study on HIV-infected pregnant women and their children
PENTA
Paediatric European Network for the Treatment of AIDS
GICQUEL Brigitte TB VACCINE CLUSTER
A Cluster for Tuberculosis Vaccine Development
GIJS Martin DETECTHIV
Sensitive Nanoparticle Assay For the Detection of HIV
GILBERT Ian Plasmodium dUTPase
Deoxyuridine Triphosphate Nucleotidohydrolase as a Drug Target against Malaria
GLÜCK Reinhard SME Malaria
SME Led Malaria Vaccine Initiative
GOMES Melba ARTESUNATE
Research and Development of Rectal Artesunate
GOUDSMIT Jaap PRIBOMAL
Preclinical Studies towards an Affordable, Safe and Efficacious Two-Component Paediatric Malaria Vaccine
GROLMUSZ Vince scrIN-SILICO
Finding Promising Drug Candidates Against Tuberculosis with
Multidisciplinary Protocol Based Non-Conventional Search
HARTMANN Marcus and BRANDT Remco CILMALVAC
The Tetrahymena system as an innovative approach to malaria antigene expression
HOELSCHER Michael CTL and HIV- super Infection
CTL-Mediated Protection from HIV-1 Infection in a High-Risk Cohort in Tanzania: Persistent Seronegativity, Persistent Single-Subtype Infection, and Cross-Subtype Superinfection
HIV-superinfections
Behavioural, Immunological and Virologic Correlates of HIV-1 Superinfection (HIV+ vs HIV++) in Rural Tanzania
HOLMES Harvey EVA
Programme EVA (European Vaccine Against Aids) Centralised Facility For Aids Reagents
HUET Jacqueline MUNANO VAC
Mucosal Nano Vaccine Candidate for HIV
HUNSMANN Gerhard ENVEP
European Network for Vaccine Evaluation in Primates: Combined Vector Immunisation for AIDS Vaccine Development
HVIID Lars HUMALMAB
Human monoclonal antibodies as tools for malaria research and therapy
JEPSEN Soeren AMVTN/AMANET
African Malaria Vaccine Testing Network
AMVTNETHIC
AMVTN Workshops on the Molecular Biology and Immunology of Malaria Vaccines
EMVDA
The European Malaria Vaccine Development AssociationThe European Malaria Vaccine Development Association
EMVI
European Malaria Vaccine Initiative
EMVI-TRIAL-PROTOCOLS
European Malaria Vaccine Clinical Trial Protocols
EURHAVAC
European Network for Harmonisation of MalariaVaccine Development
NEMLAR
AMVTN Seminar on Health Research Ethics in Africa
JOMAA Hassan NEW ANTIMALARIALS
Clinical and Pre-Clinical Evaluation of Fosmidomycin and its Derivates as Antimalarial Drugs
NEW ANTIMYCOBACTERIALS
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Drugs Against Tuberculosis
SENSITIVE TARGETS
Oxygen-Sensitive Enzymes of the Mevalonate-Independent Isoprenoid Biosynthesis Pathway as Targets for New Antimalarial and Anti-TB Drugs
KAPPES Barbara VITBIOMAL
Vitamin Biosynthesis as a Target for Antimalarial Therapy
KELLY Charles EMPRO
European Microbicides project
KERI György TB-DRUG
A SME-STREP for Tuberculosis Drug Development
KESTENS Luc TBIRIS
Pathogenesis and identification of predictive factors of TB-IRIS in HIV patients under HAART

KIECHEL Jean-Ren FACT
Development of Oral Fixed Dose Artesunate-Based Combinations for the Treatment of Uncomplicated Malaria
KLINKERT Mo PAMVAC
The Development of Vaccine Against Pregnancy-Associated Malaria - PAMVAC (Pregnancy-Associated Malaria Vaccine)
KOOPMAN Gerrit HIV COM THER
Development and Testing of a Combined Anti-Retroviral, Immune, and Gene Therapy for Treatment of HIV Patients
Pox-gene
A Combined Pox-virus/Lentiviral Vector System to Treat HIV Infection; Immunisation and Direct In Vivo Gene Transfer in T-Lymphocytes
KREMER Kristin TBADAPT
Effect of Genetic Variation in Mycobacterium Tuberculosis on Vaccine Escape and the Acquisition of Drug Resistance
KRAEUSSLICH Hans-Georg HIV PI resistance
HIV protease inhibitor resistance by enzyme- substrate coevolution
HIV PR INHIBITORS
Rational Approaches Towards Understanding and Overcoming HIV Protease Inhibitor Resistance
KULIKOWSKI Tadeusz HIVResInh
Preparation and Identification of New HIV Reverse Transcriptase Inhibitors Targeted Against HIV Strains Resistant to anti-HIV/AIDS drugs
LA COLLA Paolo SHIVA
Selection and Development of Microbicides for Mucosal Use to Prevent Sexual HIV Transmission/Acquisition
LACEY Charles no acronym
Collaboration on Vaginal Microbicides Development for the Prevention of HIV Transmission
LAGA Maria MICROBICIDES 2002
Conference Microbicides 2002 Antwerp, 12-15 May 2002
LAMBERT Paul-Henri ADVAC-EC
Advanced Vaccinology Training for Scientists from ACC and Developing Countries: From Genomics to Vaccination Strategies for Communicable Diseases Linked to Poverty
LANZER Michael ADMALI
Adhesive Interactions in Malaria: New Targets for Intervention
MALCROSS
Genetic Analysis of the Chloroquine Drug Resistance and the Accelerated-Resistance-to Multiple Drugs Phenotypes in the Human Malarial Parasite Plasmodium Falciparum
LEHNER Thomas Allomicrovac
A combined microbicidal-immunizing strategy against SIV and HIV infection
INNOVAC
Highly Innovative Strategies for Vaccination to Poverty Related Diseases
LIENHARDT Christian ACCELTB
EU Accelerated Action Against Tuberculosis: The Agenda for Africa
AFTBVAC
Development of a Tuberculosis Vaccine in Africa
OFLOTUB
A Multicentre, Randomised, Control Trial of Ofloxacine-Containing, Short-Course Regimen for the Treatment of Pulmonary Tuberculosis
LILJESTROM Peter VaccTIP
Vaccine Strategies for Combined Targeting of Innate and Adaptive Immune Pathways
EUROVAC I
European Vaccine Effort Against HIV/AIDS
EUROVAC II
European Vaccine Effort Against HIV/AIDS-II
LUDEWIG Burkhard AIDS-CoVAC
Generation of a Coronavirus-Based Multigene AIDS Vaccine and Evaluation in a Preclinical SIV model
LUND Ole Vaccines4TB
Genome- and HLA- Wide Scanning and Validation of Cytotoxic CD8 T Cell Responses against Mycobacterium Tuberculosis
LUNDGREN Jens D. EuroSIDA
The EuroSIDA network 2000-200: Clinical and Virological Outcome of European Patients Infected with HIV
EuroSIDA 2005-2009
The EuroSIDA Network 2005-2009 Clinical and Virological Outcome of Patients with HIV under Care in Europe
LYCKE Nils ISCOTB
Novel Approaches to Induce Mucosal Immunity Against TB Using the Combined Adjuvant Strategy of CTA-1 and ISCOMS
MANGANELLI Riccardo MYCOMANCY
Transcriptional Regulation And Cellular Localisation Of Mycobacterial Cell Cycle Proteins During Dormancy
MARSH P. D. MUCOSAL TB VACCINE
Role of Mucosal Immunity for Protection against Tuberculosis
NEWELL WITH C.THOME, CS.PECKHAM ML ECS
European Collaborative Study on Pregnant HIV Infected Women and Their Children
NISINI Roberto MILD-TB
Immunogenicity of Mycobacterium Tuberculosis lipids in the Non Replicating Status of latency
OGGIONI Marco R. LONG-DRUG
Characterisation of Mycobacterium Tuberculosis Populations During Infection: A Longitudinal Study on Drug Resistance Development
OLSEN Wenche Marie New cAMP antagonists
Development of Antagonists that Disrupt the Hyperactivated cAMP Signalling Pathway in Immunodeficiencies as Immunostimulatory Therapy
PANTALEO Giuseppe EuroVac-III
European Vaccine Effort Against HIV/AIDS III
PETIT Serge READ-UP
Redox Antimalarial Drug discovery
POLI Guido GISHEAL
Genetic and Immunological Studies of European and African HIV-1+ Long Term Non-Progressors
PORTAELS Françoise TB-DRUG OLIGOCOLOR
Development of a Molecular Platform for the Simultaneous Detection of Mycobacterium tuberculosis Resistance to Rifampicin and Fluoroquinolones
Upgrade Diagno MDR-TB
Improved Diagnosis, Drug Resistance Detection and Control of Tuberculosis in Latin America
PORTER Kholoud CASCADE
Concerted Action on SeroConversion to AIDS and Death in Europe
CASCADE Virology
Virological Characterisation of Primary HIV Infection in the Concerted Action on SeroConversion to AIDS and Death in Europe
POURCEL Christine Tuberculosis China
The Diversity of Mycobacterium Tuberculosis Strains in China: Tracing the Origins of the Worldwide Dispersion of the Multidrug-Resistant Beijing Genotype
PREISER Peter VIRIMAL
Structure, Function and Vaccine Potential of the Vir Multigene Family in Malaria
RACZ P.
and KLARA TENNER-RACZ
DETEC
SIV/HIV Vaccines: Detecting Efficacy and Explaining Inefficacy
MUVADEN
Mucosal Vaccines Against Human and Simian Immunodeficiency Viruses Based on Dendritic Cells
RAPPUOLI Rino MUVAPRED
Mucosal Vaccines for Poverty Related Diseases
RENIA Laurent MALINV
Differential Expression of Malaria Invasion-Associated Proteins in the porozoite: Novel Vaccination Strategy
RICCIARDI-CASTAGNOLI Paola MM-TB
Molecular Markers of M. tuberculosis Early Interactions with Host Phagocytes
ROTTENBERG Martin Neotim
Innate and adaptive immunity in clinical and experimental mycobacterial infection in neonates and infants
S A WARD AntiMal
Development of New Drugs for the Treatment of Malaria
SAKSELA Kalle TARGETING NEF
The HIV-1 Pathogenicity Factor Nef as a Novel Therapeutic Target
SANDSTROM Eric HIVIS
Study of Immunogenicity of DNA HIV-1 env, gag and pol Plasmid Vaccines Boosted with MVA in Tanzania: HIV Vaccine Immunogenicity Study
SAUERBORN Rainer MAMOP
Improving the Management of Childhood Malaria: An Experiment to Bridge the Gap Between Mothers and Healthcare Providers
SAUERWEIN R.W. MALTRANS
Project Interruption of Malaria Transmission Vaccine Strategies
SCALA Giuseppe EPI-VAC
Identification of Novel Epitopes as HIV-1 Vaccine Candidates
SCARLATTI Gabriella HIV-1 MTCT
International Network on HIV-1 Mother-to-Child Transmission: Developing Integration of Healthcare Programmes, Clinical, Social and Basic Research
NeutNet
Standardisation of HIV Neutralisation Assays to be Used in Vaccine Research and Clinical Trials
SCHERF Artur BioMalPar
Biology and Pathology of the Malaria Parasite
SCHUURMAN Rob VIRULENCE
HIV-1 Reverse Transcriptase Inhibitor Resistance and Its Consequences for Viral Virulence
SCHWARTZ Olivier NEWHIVTARGETS
Identifying novel classes of HIV inhibitors
SHATTOCK Robin EUROPRISE
European Vaccines and Microbicides Enterprise
SINGH TMahavir FASTEST-TB
Development and Clinical Evaluation of Fast Tests for Tuberculosis Diagnosis
NEWTBDRUGS
New Drugs for Persistent Tuberculosis: Exploitation of 3-D Structure of Novel Targets, Lead Optimisation and Functional In-Vivo Evaluation
PERSISTENT TB
Novel Drug Targets Specific to Persistent (Latent) Tuberculosis Infection: Crystallisation, Structure Determination and Functional Studies
SPETZ Anna-Lena Auto/AlloCell-HIV
Development of a Novel Therapeutic HIV-1 Vaccine: Horizontal Gene Transfer by Using Apoptotic HIV-1 DNA Containing Activated T-cells
STANESCU Ioana EPIVAC
Development of a multi-step Improved Epidermis Specific Vaccine Candidate against HIV/AIDS
STEWART Graham TBMACS
Identification and characterisation of Mycobacterium tuberculosis virulence genes involved in macrophage parasitism

STIEGLER Gabriela HIV VIROSOMES
Development of a New Vaccine Against HIV: Virosomes Incorporating HIV proteins
SUTTER Gerd MVACTOR
Host Immune Activation Optimised Vaccinia Virus Vectors for Vaccine Development

SWABURY Alawi CPN-YAS-PRD
Contact Point Network to Attract Young African Scientists to Participate in EU-Funded PRD Research Projects
TEMMERMAN Marleen CASA
Optimising the Use of the Syndromic Approach for STI Management and Prevention in Resource Poor Settings
THOLE Jelle TB-VAC
TB-VAC: An Integrated Project for New Vaccines against Tuberculosis
TOMEI David TB-trDNA
Evaluation of Transrenal-DNA Detection to Diagnose Tuberculosis
TREBUCQ Arnaud COCONUTKIT
Project to coordinate the write up of a protocol for a clinical trial aimed at shortening treatment for tuberculosis
TRILLA Antoni EDCTP
European and Developing Countries Clinical Trials Programme
ÜBERLA Klaus DEC-VAC
Development of a Dendritic Cell-targeted Vaccine against AIDS
TIP-VAC
Explaining and Improving Efficacy of Targeted Immunodeficiency Virus-like Particle Vaccines against AIDS
VAN DER STUYFT Patrick SN-TB DIAGNOSIS
A System Approach to Optimising Diagnosis of Smear-Negative Tuberculosis in High and Low Prevalence Countries of South America
VAN DER ZEIJST
Bernard A.M.
Immuno VacTB
A new approach for developing a less Immunosuppressive Vaccine for Tuberculosis
VAN HOLST Gerrit-Jan HIVSTOP
Development of an Effective RNA Interference-Based Anti-HIV-1 Therapy Using an SV40-Derived Vector
VAN SOOLINGEN Dick Mol.Epidemology TB
New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis
VIAL Henri NOVEL ANTIMALARIALS
Malarial Chemotherapy Targeting Plasmodial Phospholipid Biosynthesis: Implementation of a Pro-drug Strategy for Orally Active Compounds
VON LAER Dorothee VirApt
Antiviral Aptamers for Treatment of HIV-1 Infection
VOSS Gerald HIVPRIMEBOOST THERVAC
Improvement of a Therapeutic Adjuvanted Protein HIV Vaccine by Combination with DNA Immunisation in a Prime-Boost Regimen
RMVHIV
Recombinant Measles Virus as a Vector for HIV Vaccines
WATERS Andrew ATTMAL
New Genetic Technologies: Applications to Generate Attenuated Malaria Vaccines
WELDINGH Karin SERO-TB
Development of a Specific Serological Kit for the Diagnosis of TB

WITVROUW Myriam ExCellENT-HIT
Exploiting Cellular Transport of Nuclear Transcripts as HIV Innovative Therapy
TRIoH
Targeting Replication and Integration of HIV
WOLF Hans China-HIV-VacIII
Phase I/II clinical testing of Clade C-based HIV-1 Candidate Vaccines in China
HIVAB
Generation of Broadly Cross Neutralising Antibodies for Innovative Active-passive HIV Vaccination Strategies Based on Modified Ig-gene Transgenic Mice
YUTHAVONG Yongyuth PVPFDHFR
Dihydrofolate Reductase-Thymidylate Synthase from Plasmodium Vivax and P. falciparum asTargets for Antimalarial Chemotherapy
ZUMLA Alimuddin VACSEL
Longitudinal Study of Correlates of Immunity to Tuberculosis in Exposed Individuals
VACSIS
Host-Parasite Relationship in Susceptibility to Tuberculosis
 
 
top
Graphic element